509 research outputs found
Supplementary Data and Tables -Supplemental material for A survey of opinion: When to start oral anticoagulants in patients with acute ischaemic stroke and atrial fibrillation?
No full textSupplemental material, Supplementary Data and Tables for A survey of opinion: When to start oral anticoagulants in patients with acute ischaemic stroke and atrial fibrillation? by David Munn, Azmil H Abdul-Rahim, Urs Fischer, David J Werring, Thompson G Robinson and Jesse Dawson in European Stroke Journal</p
Supplemental material for The impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: A systematic review and meta-analysis
No full textSupplemental Material for The impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: A systematic review and meta-analysis by Melanie P Jensen, Oliver J Ziff, Gargi Banerjee, Gareth Ambler and David J Werring in European Stroke Journal</p
Supplemental material for Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline
No full textSupplemental Material for Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline by Catharina JM Klijn, Maurizio Paciaroni, Eivind Berge, Eleni Korompoki, Janika Kõrv, Avtar Lal, Jukka Putaala and David J Werring in European Stroke Journal</p
sj-docx-1-wso-10.1177_17474930231215660 – Supplemental material for Prevalence, patterns, and predictors of patient-reported non-motor outcomes at 30 days after acute stroke: Prospective observational hospital cohort study
No full textSupplemental material, sj-docx-1-wso-10.1177_17474930231215660 for Prevalence, patterns, and predictors of patient-reported non-motor outcomes at 30 days after acute stroke: Prospective observational hospital cohort study by Hatice Ozkan, Gareth Ambler, Gargi Banerjee, Simone Browning, Alex P Leff, Nick S Ward, Robert J Simister and David J Werring in International Journal of Stroke</p
Secondary stroke prevention in people with atrial fibrillation: treatments and trials.
No full textAtrial fibrillation is one of the most common cardiac arrhythmias and is a major cause of ischaemic stroke. Recent findings indicate the importance of atrial fibrillation burden (device-detected, subclinical, or paroxysmal and persistent or permanent) and whether atrial fibrillation was known before stroke onset or diagnosed after stroke for the risk of recurrence. Secondary prevention in patients with atrial fibrillation and stroke aims to reduce the risk of recurrent ischaemic stroke. Findings from randomised controlled trials assessing the optimal timing to introduce direct oral anticoagulant therapy after a stroke show that early start (ie, within 48 h for minor to moderate strokes and within 4-5 days for large strokes) seems safe and could reduce the risk of early recurrence. Other promising developments regarding early rhythm control, left atrial appendage occlusion, and novel factor XI inhibitor oral anticoagulants suggest that these therapies have the potential to further reduce the risk of stroke. Secondary prevention strategies in patients with atrial fibrillation who have a stroke despite oral anticoagulation therapy is an unmet medical need. Research advances suggest a heterogeneous spectrum of causes, and ongoing trials are investigating new approaches for secondary prevention in this vulnerable patient group. In patients with atrial fibrillation and a history of intracerebral haemorrhage, the latest data from randomised controlled trials on stroke prevention shows that oral anticoagulation reduces the risk of ischaemic stroke but more data are needed to define the safety profile
sj-docx-1-eso-10.1177_23969873231223814 – Supplemental material for Peri-hematomal edema shape features related to 3-month outcome in acute supratentorial intracerebral hemorrhage
No full textSupplemental material, sj-docx-1-eso-10.1177_23969873231223814 for Peri-hematomal edema shape features related to 3-month outcome in acute supratentorial intracerebral hemorrhage by Fiona Dierksen, Anh T Tran, Tal Zeevi, Ilko L Maier, Adnan I Qureshi, Pina C Sanelli, David J Werring, Ajay Malhotra, Guido J Falcone, Kevin N Sheth and Seyedmehdi Payabvash in European Stroke Journal</p
sj-docx-1-eso-10.1177_23969873221099478 – Supplemental material for European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin
No full textSupplemental material, sj-docx-1-eso-10.1177_23969873221099478 for European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin by Marta Rubiera, Ana Aires, Kateryna Antonenko, Sabrina Lémeret, Christian H Nolte, Jukka Putaala, Renate B Schnabel, Anil M Tuladhar, David J Werring, Dena Zeraatkar and Maurizio Paciaroni in European Stroke Journal</p
sj-pdf-2-eso-10.1177_23969873221099478 – Supplemental material for European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin
No full textSupplemental material, sj-pdf-2-eso-10.1177_23969873221099478 for European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin by Marta Rubiera, Ana Aires, Kateryna Antonenko, Sabrina Lémeret, Christian H Nolte, Jukka Putaala, Renate B Schnabel, Anil M Tuladhar, David J Werring, Dena Zeraatkar and Maurizio Paciaroni in European Stroke Journal</p
sj-docx-1-wso-10.1177_17474930211062478 – Supplemental material for MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage
No full textSupplemental material, sj-docx-1-wso-10.1177_17474930211062478 for MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage by Ghil Schwarz, Gargi Banerjee, Isabel C Hostettler, Gareth Ambler, David J Seiffge, Hatice Ozkan, Simone Browning, Robert Simister, Duncan Wilson, Hannah Cohen, Tarek Yousry, Rustam Al-Shahi Salman, Gregory Y H Lip, Martin M Brown, Keith W Muir, Henry Houlden, Rolf Jäger and David J Werring in International Journal of Stroke</p
Association between the Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage (ICH) associated with cerebral amyloid angiopathy and the risk of recurrent ICH: outline protocol for a population-based analysis, and external validation in a hospital-based cohort
No full textThis is an outline protocol for a study assessing the association between the Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage (ICH) associated with cerebral amyloid angiopathy and the risk of recurrent ICH.Rodrigues, Mark; Seiffge, David; Werring, David; Al-Shahi Salman, Rustam. (2018). Association between the Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage (ICH) associated with cerebral amyloid angiopathy and the risk of recurrent ICH: outline protocol for a population-based analysis, and external validation in a hospital-based cohort, [text]. https://doi.org/10.7488/ds/7479
- …
